Grilley-Olson, J. E., Bedard, P. L., Fasolo, A., Cornfeld, M., Cartee, L., Razak, A. R. A., . . . Infante, J. R. (2016). A phase Ib dose-escalation study of the MEK inhibitor trametinib in combination with the PI3K/mTOR inhibitor GSK2126458 in patients with advanced solid tumors. Invest New Drugs.
Styl ChicagoGrilley-Olson, J. E., et al. "A Phase Ib Dose-escalation Study of the MEK Inhibitor Trametinib in Combination With the PI3K/mTOR Inhibitor GSK2126458 in Patients With Advanced Solid Tumors." Invest New Drugs 2016.
Citace podle MLAGrilley-Olson, J. E., et al. "A Phase Ib Dose-escalation Study of the MEK Inhibitor Trametinib in Combination With the PI3K/mTOR Inhibitor GSK2126458 in Patients With Advanced Solid Tumors." Invest New Drugs 2016.